Market Overview:
The global computational biology market reached a value of US$ 3.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 12.8 Billion by 2027, exhibiting a CAGR of 22.1% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Computational biology, also known as bioinformatics, is the interdisciplinary branch of science that uses math, statistics and computer science for understanding and modeling the structures and processes of life. It involves various aspects of biology, such as genetics, evolution, cell biology, and biochemistry. The process uses computational techniques, including algorithms, to represent and simulate biological systems and interpret experimental data on a large scale. Computational biology also helps understand the treatment for diseases and cellular function by creating a database of biological information from amino-acid sequences, nucleotides, and macromolecular structures. Nowadays, computational biology has become an essential part of biological research projects, including the human genome project, protein data banks and genomic databases.
Computational Biology Market Trends:
The global computational biology market is primarily driven by the rising number of clinical studies in the field of pharmacogenomics. This has helped increase the understanding of the diverse biological makeup of the patient population, biological pathways, and the genomes underpinning them. As a result, there is a high demand for computational biology solutions, as they help reduce the overall time needed for drug discovery and various other scientific experiments. The process also aids the visualization of tools to simulate advanced drug-drug interactions. In addition to this, the growing demand for computational biology in epi-genomics, proteomics, and meta-genomics to undertint protein structures and interactions is also propelling the market growth. Furthermore, various technological advancements in drug development and disease modeling, along with increasing investments by private and government organizations in research and development (R&D) activities, are also anticipated to provide a positive thrust to the market in the near future.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global computational biology market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on application, services and end use.
Breakup by Application:
- Cellular and Biological Simulation
- Computational Genomics
- Computational Proteomics
- Pharmacogenomics
- Others
- Drug Discovery and Disease Modelling
- Target Identification
- Target Validation
- Lead Discovery
- Lead Optimization
- Preclinical Drug Development
- Pharmacokinetics
- Pharmacodynamics
- Clinical Trials
- Phase I
- Phase II
- Phase III
- Human Body Simulation Software
Breakup by Services:
Breakup by End Use:
- Academics
- Pharmaceutical Industry
- Commercial
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Certara, Chemical Computing Group ULC, Compugen Ltd, Dassault Systèmes, Genedata AG, Insilico Biotechnology AG, Instem plc, Nimbus Therapeutics LLC, Schrödinger Inc. and Simulations Plus Inc.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Application, Services, End Use, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Certara, Chemical Computing Group ULC, Compugen Ltd, Dassault Systèmes, Genedata AG, Insilico Biotechnology AG, Instem plc, Nimbus Therapeutics LLC, Schrödinger Inc. and Simulations Plus Inc. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Computational Biology Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Application
6.1 Cellular and Biological Simulation
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Computational Genomics
6.1.2.2 Computational Proteomics
6.1.2.3 Pharmacogenomics
6.1.2.4 Others
6.1.3 Market Forecast
6.2 Drug Discovery and Disease Modelling
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Target Identification
6.2.2.2 Target Validation
6.2.2.3 Lead Discovery
6.2.2.4 Lead Optimization
6.2.3 Market Forecast
6.3 Preclinical Drug Development
6.3.1 Market Trends
6.3.2 Key Segments
6.3.2.1 Pharmacokinetics
6.3.2.2 Pharmacodynamics
6.3.3 Market Forecast
6.4 Clinical Trials
6.4.1 Market Trends
6.4.2 Key Segments
6.4.2.1 Phase I
6.4.2.2 Phase II
6.4.2.3 Phase III
6.4.3 Market Forecast
6.5 Human Body Simulation Software
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Services
7.1 In-house
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Contract
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by End Use
8.1 Academics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Pharmaceutical Industry
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Commercial
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Certara
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.2 Chemical Computing Group ULC
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Compugen Ltd
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.4 Dassault Systèmes
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 Genedata AG
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Insilico Biotechnology AG
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Instem plc
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8 Nimbus Therapeutics LLC
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Schrödinger Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 Simulations Plus Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
List of Figures
Figure 1: Global: Computational Biology Market: Major Drivers and Challenges
Figure 2: Global: Computational Biology Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Computational Biology Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Computational Biology Market: Breakup by Application (in %), 2021
Figure 5: Global: Computational Biology Market: Breakup by Services (in %), 2021
Figure 6: Global: Computational Biology Market: Breakup by End Use (in %), 2021
Figure 7: Global: Computational Biology Market: Breakup by Region (in %), 2021
Figure 8: Global: Computational Biology (Cellular and Biological Simulation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Computational Biology (Cellular and Biological Simulation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Computational Biology (Drug Discovery and Disease Modelling) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Computational Biology (Drug Discovery and Disease Modelling) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Computational Biology (Preclinical Drug Development) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Computational Biology (Preclinical Drug Development) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Computational Biology (Clinical Trials) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Computational Biology (Clinical Trials) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Computational Biology (Human Body Simulation Software) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Computational Biology (Human Body Simulation Software) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Computational Biology (In-house) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Computational Biology (In-house) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Computational Biology (Contract) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Computational Biology (Contract) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Computational Biology (Academics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Computational Biology (Academics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Computational Biology (Pharmaceutical Industry) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Computational Biology (Pharmaceutical Industry) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Computational Biology (Commercial) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Computational Biology (Commercial) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: North America: Computational Biology Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: North America: Computational Biology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: United States: Computational Biology Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: United States: Computational Biology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Canada: Computational Biology Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Canada: Computational Biology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Asia-Pacific: Computational Biology Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Asia-Pacific: Computational Biology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: China: Computational Biology Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: China: Computational Biology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Japan: Computational Biology Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Japan: Computational Biology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: India: Computational Biology Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: India: Computational Biology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: South Korea: Computational Biology Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: South Korea: Computational Biology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Australia: Computational Biology Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Australia: Computational Biology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Indonesia: Computational Biology Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Indonesia: Computational Biology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Others: Computational Biology Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Others: Computational Biology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Europe: Computational Biology Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Europe: Computational Biology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Germany: Computational Biology Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Germany: Computational Biology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: France: Computational Biology Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: France: Computational Biology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: United Kingdom: Computational Biology Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: United Kingdom: Computational Biology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Italy: Computational Biology Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Italy: Computational Biology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Spain: Computational Biology Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Spain: Computational Biology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Russia: Computational Biology Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Russia: Computational Biology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Others: Computational Biology Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Others: Computational Biology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Latin America: Computational Biology Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Latin America: Computational Biology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Brazil: Computational Biology Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Brazil: Computational Biology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Mexico: Computational Biology Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Mexico: Computational Biology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Others: Computational Biology Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Others: Computational Biology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Middle East and Africa: Computational Biology Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Middle East and Africa: Computational Biology Market: Breakup by Country (in %), 2021
Figure 76: Middle East and Africa: Computational Biology Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Global: Computational Biology Industry: SWOT Analysis
Figure 78: Global: Computational Biology Industry: Value Chain Analysis
Figure 79: Global: Computational Biology Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Computational Biology Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Computational Biology Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 3: Global: Computational Biology Market Forecast: Breakup by Services (in Million US$), 2022-2027
Table 4: Global: Computational Biology Market Forecast: Breakup by End Use (in Million US$), 2022-2027
Table 5: Global: Computational Biology Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Computational Biology Market: Competitive Structure
Table 7: Global: Computational Biology Market: Key Players